Anteris Technologies Global (NASDAQ:AVR) Major Shareholder Sells $2,291,780.40 in Stock

August 13, 2026 by InsiderTrades.com

Key Points

Major shareholder L1 Capital continued selling: It sold 251,844 Anteris shares for $2.29 million, reducing its position by 4.63% to 5.19 million shares. The firm has disclosed more than $20 million in additional sales since late July.
Second-quarter results improved year over year but missed estimates: Anteris reported a loss of $0.30 per share versus $0.58 a year earlier, while revenue rose to $1.01 million but fell short of the $1.50 million analyst forecast.
The stock remains a development-stage, high-risk investment: Shares opened at $8.87, with a market value of about $863 million, while the company posted deeply negative margins and return on equity. Analysts nonetheless maintain a “Moderate Buy” consensus and an average price target of $16.

Anteris Technologies Global Corp. (NASDAQ:AVR - Get Free Report) major shareholder L1 Capital Pty Ltd sold 251,844 shares of the company's stock in a transaction on Monday, August 10th. The shares were sold at an average price of $9.10, for a total value of $2,291,780.40. Following the completion of the sale, the insider directly owned 5,187,156 shares in the company, valued at $47,203,119.60. This trade represents a 4.63% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Large shareholders that own more than 10% of a company's shares are required to disclose their transactions with the SEC.

L1 Capital Pty Ltd also recently made the following trade(s):

On Tuesday, August 11th, L1 Capital Pty Ltd sold 375,815 shares of Anteris Technologies Global stock. The shares were sold at an average price of $9.30, for a total value of $3,495,079.50.
On Thursday, August 6th, L1 Capital Pty Ltd sold 174,721 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.10, for a total value of $1,415,240.10.
On Tuesday, August 4th, L1 Capital Pty Ltd sold 480,608 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.30, for a total value of $3,989,046.40.
On Wednesday, August 5th, L1 Capital Pty Ltd sold 14,581 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.23, for a total transaction of $120,001.63.
On Monday, August 3rd, L1 Capital Pty Ltd sold 475,693 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.10, for a total transaction of $3,853,113.30.
On Friday, July 31st, L1 Capital Pty Ltd sold 48,711 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.15, for a total transaction of $396,994.65.
On Wednesday, July 29th, L1 Capital Pty Ltd sold 155,505 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.04, for a total transaction of $1,250,260.20.
On Thursday, July 30th, L1 Capital Pty Ltd sold 558,633 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.20, for a total transaction of $4,580,790.60.
On Monday, July 27th, L1 Capital Pty Ltd sold 232,817 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.19, for a total transaction of $1,906,771.23.
On Tuesday, July 28th, L1 Capital Pty Ltd sold 208,731 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.09, for a total transaction of $1,688,633.79.

Anteris Technologies Global Price Performance

Shares of NASDAQ AVR opened at $8.87 on Thursday. The firm's 50-day moving average is $9.15 and its two-hundred day moving average is $7.35. The company has a market capitalization of $863.42 million, a PE ratio of -4.55 and a beta of 1.78. Anteris Technologies Global Corp. has a 12-month low of $3.30 and a 12-month high of $11.06.

Anteris Technologies Global (NASDAQ:AVR - Get Free Report) last issued its quarterly earnings data on Tuesday, August 11th. The company reported ($0.30) earnings per share for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.09). Anteris Technologies Global had a negative return on equity of 110.36% and a negative net margin of 4,619.27%.The business had revenue of $1.01 million for the quarter, compared to analysts' expectations of $1.50 million. During the same period last year, the business earned ($0.58) earnings per share. On average, analysts forecast that Anteris Technologies Global Corp. will post -1.14 EPS for the current fiscal year.

Trending Headlines about Anteris Technologies Global

Here are the key news stories impacting Anteris Technologies Global this week:

Positive Sentiment: Q2 loss narrowed and sales increased: Anteris reported a second-quarter 2026 loss of $0.30 per share, an improvement from the $0.58 loss recorded a year earlier. Net sales rose to $1.01 million, although the figure remained below the $1.50 million analyst estimate. Anteris Technologies Q2 Loss Narrows, Net Sales Rise
Positive Sentiment: Medicare reimbursement eligibility supports the clinical program: The company said eligible U.S. sites in its global pivotal PARADIGM trial can receive Medicare reimbursement under a Centers for Medicare & Medicaid Services national coverage policy. This could improve trial execution and reduce financial barriers to participation. Anteris Technologies Announces Results for the Second Quarter of 2026
Neutral Sentiment: Development-stage profile remains central to the outlook: Anteris continues investing heavily in medical-device development, reflected in its extremely negative net margin and negative return on equity. Investors are likely focused on clinical milestones, commercialization prospects and future funding needs rather than near-term profitability.
Negative Sentiment: Quarterly results missed expectations: The $0.30-per-share loss was wider than the consensus estimate of $0.21, while revenue also fell short of expectations. The earnings miss can weigh on the stock despite year-over-year improvement. Anteris Technologies Global earnings report
Negative Sentiment: Major shareholder continues reducing its position: L1 Capital Pty Ltd disclosed sales of 375,815 shares on August 11 and 251,844 shares on August 10, following earlier sales including 174,721 shares on August 6. The repeated selling, totaling more than 800,000 shares across these disclosures, creates additional supply and may signal reduced conviction or portfolio rebalancing. SEC filing on L1 Capital share sales

Analyst Ratings Changes

Several equities analysts have weighed in on the company. Wall Street Zen raised Anteris Technologies Global from a "sell" rating to a "hold" rating in a research report on Saturday, May 16th. Barclays upped their price objective on Anteris Technologies Global from $17.00 to $18.00 and gave the company an "overweight" rating in a research report on Friday, May 15th. Finally, Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Anteris Technologies Global in a research note on Friday, May 29th. Four equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $16.00.

View Our Latest Research Report on AVR

Hedge Funds Weigh In On Anteris Technologies Global

Institutional investors have recently modified their holdings of the company. Russell Investments Group Ltd. raised its position in shares of Anteris Technologies Global by 76.9% in the third quarter. Russell Investments Group Ltd. now owns 6,536 shares of the company's stock valued at $29,000 after buying an additional 2,841 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in Anteris Technologies Global during the first quarter worth approximately $32,000. BNP Paribas Financial Markets boosted its position in Anteris Technologies Global by 83.3% during the third quarter. BNP Paribas Financial Markets now owns 9,469 shares of the company's stock worth $43,000 after acquiring an additional 4,302 shares during the last quarter. Bank of America Corp DE grew its stake in Anteris Technologies Global by 35.7% in the 3rd quarter. Bank of America Corp DE now owns 10,631 shares of the company's stock worth $48,000 after acquiring an additional 2,798 shares during the period. Finally, Duncan Williams Asset Management LLC purchased a new stake in Anteris Technologies Global in the 4th quarter worth approximately $54,000.

Anteris Technologies Global Company Profile

(Get Free Report)

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.